Cancellation · USPTO

Cancellation 92075897

OtherUSPTO

Cancellation 92075897 at USPTO between Hi-Tech Pharmaceuticals, Inc. and Hauora Med S.r.l., over the mark NEXRUTINE, filed Dec 7, 2020. Status in the office record: other.

View NEXRUTINEGet this data via the API
Status
Other
Result
Other
Filed
Dec 7, 2020
Marks involved
2
Parties

Who is involved

The parties as named in the office record.

Petitioner

Hi-Tech Pharmaceuticals, Inc.

Respondent

Hauora Med S.r.l.

Timeline

How the case has moved

Dates from the USPTO record and the NEXRUTINE filing.

  1. NEXRUTINE filed

    Application 76048316 filed at the USPTO.

  2. NEXRUTINE registered

  3. Cancellation filed

    Hi-Tech Pharmaceuticals, Inc. started cancellation 92075897 at USPTO against NEXRUTINE.
Marks

Marks involved

1 contested mark, 1 mark the challenger relies on.

MarkRoleApplicationOffice
NEXRUTINEContested76048316USPTO
NEXRUTINERelied on90354136USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_12868dee-41c6-4d7e-8c22-55f17c4f4e7d
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_12868dee-41c6-4d7e-8c22-55f17c4f4e7d",
  "object": "proceeding",
  "proceeding_type": "cancellation",
  "proceeding_number": "92075897",
  "status": "other",
  "office_code": "US",
  "filed_date": "2020-12-07",
  "parties": [
    {
      "name": "Hi-Tech Pharmaceuticals, Inc.",
      "role": "petitioner"
    },
    {
      "name": "Hauora Med S.r.l.",
      "role": "respondent"
    }
  ]
}